Drugs Made In America Acquisition II Corp. (DMII)
NASDAQ:DMII
DMII Stock Chart & Stats
$9.98
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$9.86 - $10.01
Previous CloseN/A
VolumeN/A
Average Volume (3M)239.93K
Market Cap
$654.44M
Enterprise Value$6.24M
Total Cash (Recent Filing)$315.09K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.02
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding65,575,000
10 Day Avg. Volume190,765
30 Day Avg. Volume239,929
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-5.39K
Price to Sales (P/S)0.00
P/FCF Ratio-3.24K
Enterprise Value/Market Cap<0.01
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-40.14
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Drugs Made In America Acquisition II Corp. News
DMII FAQ
What was Drugs Made In America Acquisition II Corp.’s price range in the past 12 months?
Drugs Made In America Acquisition II Corp. lowest stock price was $9.86 and its highest was $10.01 in the past 12 months.
What is Drugs Made In America Acquisition II Corp.’s market cap?
Drugs Made In America Acquisition II Corp.’s market cap is $654.44M.
When is Drugs Made In America Acquisition II Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Drugs Made In America Acquisition II Corp.’s earnings last quarter?
Currently, no data Available
Is Drugs Made In America Acquisition II Corp. overvalued?
According to Wall Street analysts Drugs Made In America Acquisition II Corp.’s price is currently Undervalued.
Does Drugs Made In America Acquisition II Corp. pay dividends?
Drugs Made In America Acquisition II Corp. does not currently pay dividends.
What is Drugs Made In America Acquisition II Corp.’s EPS estimate?
Drugs Made In America Acquisition II Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Drugs Made In America Acquisition II Corp. have?
Drugs Made In America Acquisition II Corp. has 65,575,000 shares outstanding.
What happened to Drugs Made In America Acquisition II Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Drugs Made In America Acquisition II Corp.?
Currently, no hedge funds are holding shares in DMII
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Drugs Made In America Acquisition II Corp. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Company Description
Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
M3-Brigade Acquisition V Corp. Class A
―
Oaktree Acquisition Corp. III Life Sciences Class A
―
Translational Development Acquisition Corp.
―
Drugs Made In America Acquisition Corp.
―
Archimedes Tech SPAC Partners II Corporation
―
Ownership Overview
―
Insiders
3.41%
Mutual Funds
40.79% Other Institutional Investors
55.72% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---